312 related articles for article (PubMed ID: 34575992)
1. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms.
Lejman M; Kuśmierczuk K; Bednarz K; Ostapińska K; Zawitkowska J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575992
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
Heikamp EB; Pui CH
J Pediatr; 2018 Dec; 203():14-24.e2. PubMed ID: 30213460
[No Abstract] [Full Text] [Related]
3. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH; Wan CL; Dai HP; Xue SL
Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
[TBL] [Abstract][Full Text] [Related]
4. Novel therapies for pediatric acute lymphoblastic leukemia.
Graff Z; Burke MJ; Gossai N
Curr Opin Pediatr; 2024 Feb; 36(1):64-70. PubMed ID: 37991046
[TBL] [Abstract][Full Text] [Related]
5. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
[No Abstract] [Full Text] [Related]
6. [Precision medicine and molecular target drugs in pediatric hematologic malignancies: acute lymphoblastic leukemia].
Takita J
Rinsho Ketsueki; 2020; 61(6):657-664. PubMed ID: 32624540
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of acute lymphoblastic leukemia.
Rafei H; Kantarjian HM; Jabbour EJ
Leuk Lymphoma; 2019 Nov; 60(11):2606-2621. PubMed ID: 31092071
[TBL] [Abstract][Full Text] [Related]
8. [ALL in adult patients: Contribution and limits of pediatric management].
Rabian F; Boissel N
Bull Cancer; 2021 Feb; 108(2):187-197. PubMed ID: 32981690
[TBL] [Abstract][Full Text] [Related]
9. Agents in Development for Childhood Acute Lymphoblastic Leukemia.
Maloney KW; Gore L
Paediatr Drugs; 2018 Apr; 20(2):111-120. PubMed ID: 29143289
[TBL] [Abstract][Full Text] [Related]
10. Therapy for childhood acute lymphoblastic leukemia.
Cassano WF; Eskenazi AE; Frantz CN
Curr Opin Oncol; 1993 Jan; 5(1):42-52. PubMed ID: 8427893
[TBL] [Abstract][Full Text] [Related]
11. Relapsed childhood acute lymphoblastic leukaemia.
Bhojwani D; Pui CH
Lancet Oncol; 2013 May; 14(6):e205-17. PubMed ID: 23639321
[TBL] [Abstract][Full Text] [Related]
12. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
Tasian SK; Loh ML; Hunger SP
Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
[TBL] [Abstract][Full Text] [Related]
13. The future of cellular immunotherapy for childhood leukemia.
Bonifant CL; Tasian SK
Curr Opin Pediatr; 2020 Feb; 32(1):13-25. PubMed ID: 31851053
[TBL] [Abstract][Full Text] [Related]
14. Progress in adult ALL: incorporation of new agents to frontline treatment.
Leonard J; Stock W
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):28-36. PubMed ID: 29222234
[TBL] [Abstract][Full Text] [Related]
15. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
Hochberg J; El-Mallawany NK; Cairo MS
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
[TBL] [Abstract][Full Text] [Related]
17. [Acute Lymphoblastic Leukemia - Diagnostics, Subgroups and Therapies].
Wermann WK; Gökbuget N
Dtsch Med Wochenschr; 2018 Sep; 143(18):1311-1317. PubMed ID: 30199911
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia.
Silverman LB
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):259-264. PubMed ID: 29222264
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted treatment of pediatric acute lymphoblastic leukemia.
Jeha S; Pui CH
Hematol Oncol Clin North Am; 2009 Oct; 23(5):973-90, v. PubMed ID: 19825448
[TBL] [Abstract][Full Text] [Related]
20. Pediatric acute lymphoblastic leukemia.
Inaba H; Mullighan CG
Haematologica; 2020 Nov; 105(11):2524-2539. PubMed ID: 33054110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
